The potential impact of CYP and UGT drug-metabolizing enzymes on brain target site drug exposure

Drug Metabolism Reviews · Published 2023-12-21 · DOI 10.1080/03602532.2023.2297154

Authors being retrieved — see the publisher record. https://doi.org/10.1080/03602532.2023.2297154

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2023

Related articles

• Genetic determinants of paclitaxel-induced peripheral neuropathy: a review of current literature · Drug Metabolism Reviews · 2025 · Same journal
• Bioactivation and reactivity research advances – 2023 year in review · Drug Metabolism Reviews · 2024 · Same journal
• Herb-drug interaction potential of Astragali Radix : a metabolic perspective · Drug Metabolism Reviews · 2024 · Same journal
• Scaling factors to inform in vitro - in vivo extrapolation from preclinical and livestock animals: state of the field and recommendations for development of missing data · Drug Metabolism Reviews · 2025 · Same journal
• Drug transporters in drug disposition – highlights from the year 2024 · Drug Metabolism Reviews · 2025 · Same journal
• Cytochrome P450-derived arachidonic acid metabolites as emerging therapeutic targets in menopause-associated cardiac hypertrophy · Drug Metabolism Reviews · 2026 · Same journal
• Review on the application of metalloporphyrin catalysts as cytochrome P450 enzyme mimics in biomimetic modeling · Drug Metabolism Reviews · 2026 · Same journal
• Analytical techniques for methyldopa and metabolites: a comprehensive review · Drug Metabolism Reviews · 2025 · Same journal
• Phase II metabolism in xenobiotic biotransformation: general mechanisms and the underestimated role of microbial systems · Drug Metabolism Reviews · 2025 · Same journal
• A review on analytical perspectives for cyclophosphamide, its metabolites, and impurities · Drug Metabolism Reviews · 2026 · Same journal